Publications

The Global Fund is partnering with governments, medical experts, advocates, civil society and people living with HIV, TB and malaria to fight the three diseases in the Asia-Pacific region. A total of US$6.6 billion has been invested in treating and preventing the diseases in the Asia-Pacific region, and in building more resilient and sustainable systems for health. This equates to approximately one-quarter of total Global Fund financial resources.

Faith communities play a fundamental role in addressing health challenges around the world. For decades, these organizations have been providing lifesaving prevention, care and treatment to those in need. Many hospitals and clinics around the world can trace their roots to people of faith and are still being managed by churches and other religious bodies. Faith leaders and institutions have also been fundamental in addressing stigma and educating communities about health. Faith-based organizations are essential providers of rural health care in many parts of the developing world and play an important role in serving the hard-to-reach and poorest population groups. Recognizing these unique achievements and the critical role of faith-based organizations, the Global Fund encourages their participation through diverse ways such as grant implementation, building local capacity, advocacy, and fundraising.

Agenda 2030 provides a focus for renewed ambition. It recognises that peace and sustainable development are interlinked, and sets targets to end all forms of violence against children. The Global Partnership to End Violence Against Children provides a platform for national governments, civil society, faith-based groups, academics, the private sector, international organisations and other partners to work together to deliver these targets. The Partnership was invited to make a technical support and learning visit to the Philippines (11-15 April 2016). Meetings were held with government and non-governmental partners with the aim of sharing and discussing experience of the Philippines and other countries in preventing and addressing violence against children.

In Laos, LINKAGES is taking both fear of harassment and lack of access out of the testing equation for men who have sex with men (MSM) and transgender women in three communities. The project introduced a community-based model of HIV testing with OraQuick—a relatively new rapid oral HIV test that requires neither specialized equipment nor highly trained providers to administer it. Community-based testing with OraQuick has numerous benefits. After the first three months of implementation, CBSs proved that they could reach significant numbers of MSM and trans women with HIV testing using OraQuick. Between October and December 2015, LaoPHA CBSs tested 789 MSM and transgender women using OraQuick: 773 were screened nonreactive (HIV negative), 14 reactive (presumed HIV positive, but needs another test to confirm the results), and 2 invalid. Out of the 16 people who tested reactive or invalid, only 5 went for a confirmatory HIV test. All five were confirmed HIV positive and subsequently enrolled in care.

In this policy brief, Young Lives looks at child marriage rates in India to help inform policy and programming efforts. Based on a sample of 1000 19-year-olds in the states of Andhra Pradesh and Telangana, they found that 28% of girls and just 1% of boys were married before the age of 18. By the age of 19, a majority (59%) of married young women had already given birth. The brief provides five promising areas of intervention to address child marriage and early childbearing.

The Partnership for Maternal, Newborn & Child Health is fully aligned with the Every Woman Every Child (EWEC) movement and the Global Strategy for Women’s, Children’s and Adolescents’ Health. We share a vision of a world in which every woman, child and adolescent in every setting realises their rights to physical and mental health and well-being, has social and economic opportunities and is able to participate fully in shaping prosperous and sustainable societies. Collectively, we have the knowledge, the tools, and the capability to achieve this vision. The multi-stakeholder platform created by the Partnership engages, aligns and holds accountable the efforts of all Partners so that together, we can fully harness our collective capability to achieve more than any individual Partner could do alone.  

The Annual Report 2015 provides a summary of key activities conducted by the NSACP during 2015 and data on STI and HIV reported from all the STD clinics. NSACP strongly believes in the importance of STI surveillance in the current low HIV prevalence context.

Evidence supports the need for a shift in the global approach to drug use. In this report, Do no harm: health, human rights and people who use drugs, UNAIDS shows what works to reduce the impact of HIV and other harms related to drug use. Countries that have moved away from laws and policies that are harmful to people who use drugs and that have increased investment in harm reduction have reduced new HIV infections and improved health outcomes. These policies also deliver broader social benefits, such as lower levels of drug-related crime and reduced pressure on health-care and criminal justice systems.

During the nine review windows of the 2014-2016 allocation-based funding model, the Technical Review Panel (TRP) reviewed 222 concept notes from 106 countries, including 30 regional concept notes, with a total value of US$13.8 billion representing 94 percent of allocated funds. Drawing from the TRP’s consolidated learning, observations and experiences from reviewing concept notes during this funding model, this report looks forward and focuses on contributing to the next Global Fund strategy and its operationalization. The report aligns with Global Fund’s 2017-2022 Strategy "Investing to End Epidemics," and provides a number of recommendations under each strategic objective, based on the observations of the Technical Review Panel (TRP). 

The Global Fund is focusing sharply on women and girls, making strategic investments to improve their health and supporting country-driven processes grounded in equity and inclusiveness. Our commitment to women and girls has steadily increased in the past five years. In 2010, approximately 46 percent of programs were focused on women and girls; in 2015, approximately 55 to 60 percent of the Global Fund’s spending was directed to women and girls. That translates to investments of between US$15 billion and US$16 billion since 2002. It is making a difference. Between 2005 and 2014, AIDS-related deaths among women aged 15 years and above declined 58 percent in 13 key African countries where the Global Fund invests, while declining 39 percent among men the same age. Antiretroviral (ARV) therapy coverage is becoming available to more women, and more women are staying on treatment. In many countries, rates of new HIV infections have been dropping faster among men than among women. However, experience in high-HIV burden countries in Africa with Global Fund-supported programs shows that the new infection rates are declining equally among women and men.